Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Lipidomic profiling in Crohn's disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition.

Sewell GW, Hannun YA, Han X, Koster G, Bielawski J, Goss V, Smith PJ, Rahman FZ, Vega R, Bloom SL, Walker AP, Postle AD, Segal AW.

Int J Biochem Cell Biol. 2012 Nov;44(11):1839-46. doi: 10.1016/j.biocel.2012.06.016. Epub 2012 Jun 19.

2.

Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.

Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi RH, Wiedmann M, McDonough P, Kim SG, Berg D, Schukken Y, Scherl E, Simpson KW.

ISME J. 2007 Sep;1(5):403-18. Epub 2007 Jul 12.

PMID:
18043660
3.

Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy.

Nguyen HT, Dalmasso G, Müller S, Carrière J, Seibold F, Darfeuille-Michaud A.

Gastroenterology. 2014 Feb;146(2):508-19. doi: 10.1053/j.gastro.2013.10.021. Epub 2013 Oct 19.

PMID:
24148619
4.

The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients.

Sadaghian Sadabad M, Regeling A, de Goffau MC, Blokzijl T, Weersma RK, Penders J, Faber KN, Harmsen HJ, Dijkstra G.

Gut. 2015 Oct;64(10):1546-52. doi: 10.1136/gutjnl-2014-307289. Epub 2014 Sep 24.

PMID:
25253126
5.

Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.

Sanders TJ, McCarthy NE, Giles EM, Davidson KL, Haltalli ML, Hazell S, Lindsay JO, Stagg AJ.

Gastroenterology. 2014 May;146(5):1278-88.e1-2. doi: 10.1053/j.gastro.2014.01.057. Epub 2014 Feb 4.

PMID:
24503130
6.

Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, Palmer CD, Wilde J, Foxwell BM, Gloger IS, Sweeting T, Marsh M, Walker AP, Bloom SL, Segal AW.

J Exp Med. 2009 Aug 31;206(9):1883-97. doi: 10.1084/jem.20091233. Epub 2009 Aug 3. Erratum in: J Exp Med. 2009 Sep 28;206(10):2301.

7.

Presence of group IIa secretory phospholipase A2 in mast cells and macrophages in normal human ileal submucosa and in Crohn's disease.

Lilja I, Gustafson-Svärd C, Franzeń L, Sjödahl R, Andersen S, Johansen B.

Clin Chem Lab Med. 2000 Dec;38(12):1231-6.

PMID:
11205686
8.

Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease.

Doorenspleet ME, Westera L, Peters CP, Hakvoort TBM, Esveldt RE, Vogels E, van Kampen AHC, Baas F, Buskens C, Bemelman WA, D'Haens G, Ponsioen CY, Te Velde AA, de Vries N, van den Brink GR.

J Crohns Colitis. 2017 Jul 1;11(7):831-839. doi: 10.1093/ecco-jcc/jjx012.

PMID:
28158397
9.

Lipid and phospholipid profile after bowel resection for Crohn's disease.

Romanato G, Scarpa M, Ruffolo C, Marin R, Zambon S, Zanoni S, Basato S, Filosa T, Pilon F, Angriman I, Manzato E.

Int J Colorectal Dis. 2008 Oct;23(10):931-8. doi: 10.1007/s00384-008-0503-3. Epub 2008 Jul 3.

PMID:
18597099
10.

Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.

Vazeille E, Buisson A, Bringer MA, Goutte M, Ouchchane L, Hugot JP, de Vallée A, Barnich N, Bommelaer G, Darfeuille-Michaud A.

J Crohns Colitis. 2015 May;9(5):410-20. doi: 10.1093/ecco-jcc/jjv053. Epub 2015 Mar 24.

PMID:
25805890
11.

Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.

Miklavcic JJ, Hart TD, Lees GM, Shoemaker GK, Schnabl KL, Larsen BM, Bathe OF, Thomson AB, Mazurak VC, Clandinin MT.

World J Gastroenterol. 2015 Sep 21;21(35):10080-90. doi: 10.3748/wjg.v21.i35.10080.

12.

Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease.

Deuring JJ, Fuhler GM, Konstantinov SR, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.

Gut. 2014 Jul;63(7):1081-91. doi: 10.1136/gutjnl-2012-303527. Epub 2013 Aug 20.

PMID:
23964099
13.

Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.

Söderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, Sherman PM, Croitoru K, Perdue MH.

Gut. 2004 Dec;53(12):1817-24.

14.

Activation of nuclear factor kappa B in Crohn's disease.

Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA.

Inflamm Res. 1998 Nov;47(11):440-5.

PMID:
9865503
15.

Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

Camont L, Lhomme M, Rached F, Le Goff W, Nègre-Salvayre A, Salvayre R, Calzada C, Lagarde M, Chapman MJ, Kontush A.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2715-23. doi: 10.1161/ATVBAHA.113.301468. Epub 2013 Oct 3.

PMID:
24092747
16.

CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease.

Salim SY, Silva MA, Keita AV, Larsson M, Andersson P, Magnusson KE, Perdue MH, Söderholm JD.

Am J Pathol. 2009 Jan;174(1):82-90. doi: 10.2353/ajpath.2009.080273. Epub 2008 Dec 18.

17.

Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.

Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL.

Gut. 2008 Jul;57(7):903-10. doi: 10.1136/gut.2007.142588. Epub 2008 Feb 27.

PMID:
18305068
19.

Role of the advanced glycation end products receptor in Crohn's disease inflammation.

Ciccocioppo R, Vanoli A, Klersy C, Imbesi V, Boccaccio V, Manca R, Betti E, Cangemi GC, Strada E, Besio R, Rossi A, Falcone C, Ardizzone S, Fociani P, Danelli P, Corazza GR.

World J Gastroenterol. 2013 Dec 7;19(45):8269-81. doi: 10.3748/wjg.v19.i45.8269.

20.

Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease.

Elliott TR, Rayment NB, Hudspith BN, Hands RE, Taylor K, Parkes GC, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Bustin SA, Sanderson JD.

BMC Gastroenterol. 2015 Jul 3;15:75. doi: 10.1186/s12876-015-0305-3.

Supplemental Content

Support Center